In Stock
Tesamorelin is a 44-amino-acid GHRH analogue carrying a trans-3-hexenoic-acid N-terminal modification that blocks DPP-IV cleavage, conferring extended plasma stability over native GHRH.
It is studied in preclinical endocrine-research models for its role in pulsatile GH-axis signalling, IGF-1 feedback loops, and visceral-adipose pathway biology. CAS 901758-09-6, MW 5,135.9 Da, C₂₂₁H₃₆₆N₇₂O₆₇S.
Supplied as a lyophilised powder at ≥99% HPLC-verified purity. For laboratory research use only. Not for human or veterinary consumption. By purchasing, the buyer agrees to use this product in accordance with all applicable laws and standard research practice.
⚠ Research Use Only
This product is intended for laboratory research purposes only. Not for human consumption, veterinary use, or diagnostic procedures. Purchaser must be 18 years or older.
Tesamorelin is a 44-amino-acid GHRH analogue carrying a trans-3-hexenoic-acid N-terminal modification that blocks DPP-IV cleavage, conferring extended plasma stability over native GHRH.
It is studied in preclinical endocrine-research models for its role in pulsatile GH-axis signalling, IGF-1 feedback loops, and visceral-adipose pathway biology. CAS 901758-09-6, MW 5,135.9 Da, C₂₂₁H₃₆₆N₇₂O₆₇S.
Supplied as a lyophilised powder at ≥99% HPLC-verified purity. For laboratory research use only. Not for human or veterinary consumption. By purchasing, the buyer agrees to use this product in accordance with all applicable laws and standard research practice.
⚠ Research Use Only
This product is intended for laboratory research purposes only. Not for human consumption, veterinary use, or diagnostic procedures. Purchaser must be 18 years or older.
⚠
For research use only. This product is intended exclusively for in-vitro research and laboratory applications. Not approved for human or animal consumption, medical treatment, or therapeutic use.
